The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Protective Effects of Carvedilol Against Anthracycline-Induced Cardiomyopathy
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Effect of carvedilol on survival in severe chronic heart failure
Packer, M., Coats, A. J. S., Fowler, M. B., Katus, H. A., Krum, H., Mohacsi, P., Rouleau, J. L., Tendera, M., Castaigne, A., Roecker, E. B., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105313442201 · Cited by 3,093
Teichholz, L. E., Kreulen, T., Herman, M. V., & Gorlin, R. (1976) · The American Journal of Cardiology · doi:10.1016/0002-9149(76)90491-4 · Cited by 2,571
Effect of carvedilol on survival in severe chronic heart failure
Packer, M., Coats, A. J. S., & Fowler, M. B. (2001) · ACC Current Journal Review · doi:10.1016/s1062-1458(01)00477-9 · Cited by 1,661
Ide, T., Tsutsui, H., Kinugawa, S., Utsumi, H., Kang, D., Hattori, N., Uchida, K., Arimura, K.-I., Egashira, K., & Takeshita, A. (1999) · Circulation Research · doi:10.1161/01.res.85.4.357 · Cited by 700
Doxorubicin cardiotoxicity: analysis of prevailing hypotheses
Olson, R. D., & Mushlin, P. S. (1990) · The FASEB Journal · doi:10.1096/fasebj.4.13.2210154 · Cited by 690
Oh, J. K., Appleton, C. P., Hatle, L. K., Nishimura, R. A., Seward, J. B., & Tajik, A. J. (1997) · Journal of the American Society of Echocardiography · doi:10.1016/s0894-7317(97)70062-2 · Cited by 629
Dulin, B., & Abraham, W. T. (2004) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2004.01.003 · Cited by 311
Doxorubicin-induced apoptosis: Implications in cardiotoxicity
Kalyanaraman, B., Joseph, J., Kalivendi, S., Wang, S., Konorev, E., & Kotamraju, S. (2002) · Oxygen/Nitrogen Radicals: Cell Injury and Disease · doi:10.1007/978-1-4615-1087-1_13 · Cited by 296
Spallarossa, P., Garibaldi, S., Altieri, P., Fabbi, P., Manca, V., Nasti, S., Rossettin, P., Ghigliotti, G., Ballestrero, A., & Patrone, F. (2004) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2004.05.024 · Cited by 294
Doxorubicin-induced apoptosis: Implications in cardiotoxicity
Kalyanaraman, B., Joseph, J., Kalivendi, S., Wang, S., Konorev, E., & Kotamraju, S. (2002) · Molecular and Cellular Biochemistry · doi:10.1023/a:1015976430790 · Cited by 293
Anthracycline-derived chemotherapeutics in apoptosis and free radical cytotoxicity (Review).
Müller, I., Niethammer, D., & Bruchelt, G. (1998) · International Journal of Molecular Medicine · doi:10.3892/ijmm.1.2.491 · Cited by 180
Carvedilol Protects against Doxorubicin-Induced Mitochondrial Cardiomyopathy
Santos, D. (2002) · Toxicology and Applied Pharmacology · doi:10.1006/taap.2002.9532 · Cited by 174
Anthracycline-induced cardiomyopathy
KEEFE, D. (2001) · Seminars in Oncology · doi:10.1016/s0093-7754(01)90193-9 · Cited by 169
Dandona, P., Karne, R., Ghanim, H., Hamouda, W., Aljada, A., & Magsino, C. H. (2000) · Circulation · doi:10.1161/01.cir.101.2.122 · Cited by 140
Mitochondria-Mediated Cell Injury,
Wallace, K. B., Eells, J. T., Madeira, V. M., Cortopassi, G., & Jones, D. P. (1997) · Fundamental and Applied Toxicology · doi:10.1006/faat.1997.2320 · Cited by 133
Carvedilol: Molecular and Cellular Basis for Its Multifaceted Therapeutic Potential
Cheng, J., Kamiya, K., & Kodama, I. (2001) · Cardiovascular Drug Reviews · doi:10.1111/j.1527-3466.2001.tb00061.x · Cited by 125
Effect of β-Blockers on Free Radical–Induced Cardiac Contractile Dysfunction
Flesch, M., Maack, C., Cremers, B., Bäumer, A. T., Südkamp, M., & Böhm, M. (1999) · Circulation · doi:10.1161/01.cir.100.4.346 · Cited by 123
Mitochondria-Mediated Cell Injury
Wallace, K. B., Eells, J. T., Madeira, V. M. C., Cortopassi, G. A., & Jones, D. P. (1997) · Toxicological Sciences · doi:10.1093/toxsci/38.1.23 · Cited by 121
Tjeerdsma, G., Meinardi, M. T., van der Graaf, W. T. A., van den Berg, M. P., Mulder, N. H., Crijns, H. J. G. M., de Vries, E. G. E., & van Veldhuisen, D. J. (1999) · Heart · doi:10.1136/hrt.81.4.419 · Cited by 115
Protective effects of carvedilol against doxorubicin-induced cardiomyopathy in rats
Matsui, H., Morishima, I., Numaguchi, Y., Toki, Y., Okumura, K., & Hayakawa, T. (1999) · Life Sciences · doi:10.1016/s0024-3205(99)00362-8 · Cited by 103
Matrix metalloproteinase activation is an early event in doxorubicin-induced cardiotoxicity
Bai, P., Mabley, J. G., Liaudet, L., Virág, L., Szabó, C., & Pacher, P. (2004) · Oncology Reports · doi:10.3892/or.11.2.505 · Cited by 74
Effects of Carvedilol and Its Analog BM-910228 on Mitochondrial Function and Oxidative Stress
Abreu, R. M. V., Santos, D. L., & Moreno, A. J. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39002-0 · Cited by 67
Koitabashi, N., Arai, M., Tomaru, K., Takizawa, T., Watanabe, A., Niwano, K., Yokoyama, T., Wuytack, F., Periasamy, M., Nagai, R., et al. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.12.139 · Cited by 58
Oliveira, P. J., Rolo, A. P., Sardão, V. A., Monteiro, P. F., Gonçalves, L. M. M., Providência, L. A., Palmeira, C. M., & Moreno, A. J. (2004) · PubMed · Cited by 13
Mice primed with swainsonine are protected against doxorubicin-induced lethality.
Oredipe, O. A., Furbert-Harris, P. M., Laniyan, I., Wr, G., Griffin, W. M., & Sridhar, R. (2003) · PubMed · Cited by 11
Cited by
Heidenreich, P. A., Bozkurt, B., Aguilar, D., Allen, L. A., Byun, J. J., Colvin, M. M., Deswal, A., Drazner, M. H., Dunlay, S. M., Evers, L. R., et al. (2022) · Circulation · doi:10.1161/cir.0000000000001063 · Cited by 4,922
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure
Heidenreich, P. A., Bozkurt, B., Aguilar, D., Allen, L. A., Byun, J. J., Colvin, M. M., Deswal, A., Drazner, M. H., Dunlay, S. M., Evers, L. R., et al. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.12.012 · Cited by 2,862
Zamorano, J. L., Lancellotti, P., Rodriguez Muñoz, D., Aboyans, V., Asteggiano, R., Galderisi, M., Habib, G., Lenihan, D. J., Lip, G. Y. H., Lyon, A. R., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw211 · Cited by 2,544
Plana, J. C., Galderisi, M., Barac, A., Ewer, M. S., Ky, B., Scherrer-Crosbie, M., Ganame, J., Sebag, I. A., Agler, D. A., Badano, L. P., et al. (2014) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2014.07.012 · Cited by 1,795
Zamorano, J. L., Lancellotti, P., Rodriguez Muñoz, D., Aboyans, V., Asteggiano, R., Galderisi, M., Habib, G., Lenihan, D. J., Lip, G. Y. H., Lyon, A. R., et al. (2017) · European Journal of Heart Failure · doi:10.1002/ejhf.654 · Cited by 1,795
Metadata
- Authors
- Kalay, N., Basar, E., Ozdogru, I., Er, O., Cetinkaya, Y., Dogan, A., Oguzhan, A., Eryol, N. K., Topsakal, R., Ergin, A., & Inanc, T.
- Venue
- Journal of the American College of Cardiology
- Publisher
- Elsevier BV
- Published
- 2006-12
- Volume
- 48
- Issue
- 11
- Pages
- 2258-2262
- ISSN
- 0735-1097 (ISSN-L)
- OpenAlex
- W1998141986
- Cited by
- 713
- References
- 25
- FWCI
- 10.72
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.